← brief for 2026-08-27 · Slowing decline

Comparative Effectiveness of Combination Therapy in Patients with Chronic Kidney Disease and Diabetes mellitus Type 2 using Real World Data.

Article C Peer reviewed Observational

Key takeaways

Researchers used a large US database of real patient records to compare drug combinations in people who have both kidney disease and type 2 diabetes. Everyone was on the standard kidney-protecting blood pressure drugs (called RAAS inhibitors). The study looked at whether adding newer diabetes drugs, SGLT2 inhibitors or GLP-1 drugs, or both, worked better than the standard drugs alone. This is an observational study built from records, not a randomized trial, so it shows a link and cannot prove the combinations caused the better outcomes; sicker or healthier patients may have been given different drugs to begin with.

Who did this work

Casper J · Doricic J · Tian Z · Willerding JM · Glammeier M · Melk A · Schmidt-Ott K · Schmidt BMW

Source

Article · PubMed, the drug frontier · 2026 Aug 27
https://pubmed.ncbi.nlm.nih.gov/42658186/